The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
Published version of a preprint
Abstract
Purpose: We developed a novel systemic immune-inflammation index (SII) based on lymphocyte, neutrophil, and platelet counts and explored its prognostic value in hepatocellular carcinoma (HCC). Experimental Design: The SII was developed based on a retrospective study of 133 patients with HCC undergoing resection between 2005 and 2006, and validated in a prospective study of 123 patients enrolled from 2010 to 2011. The circulating tumor cell (CTC) level in the validation cohort was measured using the CellSearch system. Prediction accuracy was evaluated with area under the receiver operating characteristic curve (AUC). Results: An optimal cutoff point for the SII of 330 × 109 stratified the patients with HCC into high (≥330) and low SII (<330) groups in the training cohort. Univariate and multivariate analyses revealed the SII was an independent predictor for overall survival and relapse-free survival, and prognostic for patients with negative α-fetoprotein and Barcelona Clinic Liver Cancer stage 0+A. The AUCs of the SII for survival and recurrence were higher than other conventional clinical indices. An SII ≥ 330 was significantly associated with vascular invasion, large tumors, and early recurrence. CTC levels were significantly higher in the SII ≥ 330 group (1.71 ± 0.34 vs. 4.37 ± 1.04, P = 0.029). In patients with detectable CTCs, those with SII ≥ 330 had higher recurrence rates and shorter survival time than patients with SII < 330. Conclusion: The SII was a powerful prognostic indicator of poor outcome in patients with HCC and is a promising tool for HCC treatment strategy decisions. The dismal outcome in patients with high SII scores might be related to higher CTC levels. Clin Cancer Res; 20(23); 6212–22. ©2014 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The systemic immunity-inflammation index (SII) is a stable new inflammatory biomarker computed from platelet count × neutrophil count/lymphocyte count [7,8].”
From Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) (2023) · cites this paper as [7]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“In addition to the tumor cells, immune and inflammatory cells such as neutrophils, platelets, and lymphocytes also contribute to tumor cell invasion into the peripheral blood,where the tumor cells can survive and reseed distant organs (6).”
BackgroundJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 2×
“cates that neutrophils can enhance cancer cell invasion, proliferation, and metastasis as well as assist cancer cells with evading immune surveillance (16, 32).”
BackgroundCancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474 · cited 1×
“In addition, we also found that an elevated SII was associated with vascular invasion, early recurrence, and a larger tumor size, indicating a more aggressive phenotype (4, 33).”
BackgroundA Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807 · cited 2×
“Hematogenous spread is an important cause of recurrence and metastasis in HCC, and circulating tumor cells (CTC) in the bloodstream play an important role in HCC metastasis (4, 5).”
BackgroundCamp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027 · cited 1×
“cates that neutrophils can enhance cancer cell invasion, proliferation, and metastasis as well as assist cancer cells with evading immune surveillance (16, 32).”
BackgroundLabelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
Prognostic prediction and treatment strategy in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2002) · Hepatology · doi:10.1053/jhep.2002.32089 · Cited by 1,099 · cited 1×
“Tumor stage was determined according to the BarcelonaClinic LiverCancer (BCLC) stage (21).”
Method
Cited by
Systemic immune-inflammation index for predicting prognosis of colorectal cancer
Chen, J.-H., Zhai, E.-T., Yuan, Y.-J., Wu, K.-M., Xu, J.-B., Peng, J.-J., Chen, C.-Q., He, Y.-L., & Cai, S.-R. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i34.6261 · Cited by 723
Yang, Y., Wu, C., Hsu, P., Chen, S., Huang, S., Chan, W. L., Lin, S., Chou, C., Chen, J., Pan, J., et al. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13230 · Cited by 692
Systemic inflammation markers and cancer incidence in the UK Biobank
Nøst, T. H., Alcala, K., Urbarova, I., Byrne, K. S., Guida, F., Sandanger, T. M., & Johansson, M. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00752-6 · Cited by 526
“Specifically, four ratios have been highlighted by previous studies as related to morbidity and mortality, including neutrophil-to-lymphocyte ratio (NLR), plateletto-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR) and the systemic immune-inflammation index (SII) based on peripheral lymphocyte, neutrophil, m…”
MethodFucà, G., Guarini, V., Antoniotti, C., Morano, F., Moretto, R., Corallo, S., Marmorino, F., Lonardi, S., Rimassa, L., Sartore-Bianchi, A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0894-7 · Cited by 398
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
Yang, R., Chang, Q., Meng, X., Gao, N., & Wang, W. (2018) · Journal of Cancer · doi:10.7150/jca.25691 · Cited by 441
Self-citation
Metadata
- Authors
- Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., & Fan, J.
- Affiliations
- Fudan University (CN)
- Corresponding author
- Fan, Jia
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2014-11-30
- Volume
- 20
- Issue
- 23
- Pages
- 6212-6222
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2107934474
- Cited by
- 2,493
- References
- 37
- Citations by year
- 2026: 470 · 2025: 521 · 2024: 486 · 2023: 321 · 2022: 226 · 2021: 188 · 2020: 104 · 2019: 70 · 2018: 46 · 2017: 33 · 2016: 20 · 2015: 7
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- systemic immune-inflammation index, hepatocellular carcinoma, prognostic factors, curative resection, circulating tumor cells, lymphocyte count, neutrophil count, platelet count, tumor recurrence, overall survival, vascular invasion, alpha-fetoprotein, Barcelona Clinic Liver Cancer staging
- MeSH terms
- Adult, Aged, Female, Carcinoma, Hepatocellular, Humans, Inflammation, Liver Neoplasms, Male, Middle Aged, Neoplasm Recurrence, Local, Prognosis, Retrospective Studies, Risk Factors, Cohort Studies, Tumor Burden, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-14-0442
- The paper
- Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., & Fan, J. (2014). Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-14-0442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.